BCL2 gain/amplification are commonly associated with the DLBCL activated B-cell-like (ABC) subtype and mantle cell lymphoma (MCL), two aggressive types of NHL (18,19). This evidence concerns the gene BCL2 and non-Hodgkin lymphoma.